Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma
International Journal of Nanomedicine · 2025-04 · Volume 20 · 5475-5488
DOI: 10.2147/ijn.s511286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-04. Verfasst von Agnieszka Stawarska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Glioma, Integrin alphaVbeta3, Carbon, Iron. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Targeting integrin receptors for MRI represents a novel method in diagnosing glioblastoma. In the present study carbon-encapsulated iron nanoparticles to explore murine glioma tracking based upon specific direct targeting with monoclonal antibodies against the beta-3 subunit (CD61) of the integrin αVβ3 receptor are described.
Methods
The carbon arc discharge method was used to synthesize nanoparticles and amidation-type reaction were applied to attach monoclonal antibody (anti-CD61) with acidic group functionalized nanoparticles to lead two types of bioconjugates (Fe@C-CONH-anti-CD61 and Fe@C-(CH2)2-CONH-anti-CD61). The as-synthesized bioconjugates were tested on murine glioma cells (GL261) using MTT, LDH and calcein AM/propidium iodide assays. Relaxometry measurements were performed with a 1.5 T (63 MHz) MRI scanner using both GL261 cells and C57BL/6 mice bearing GL261 tumors.
Results
The results showed that Fe@C-CONH-anti-CD61 and Fe@C-(CH2)2-CONH-anti-CD61 nanoparticles have higher binding affinity towards GL261 cells compared to pristine nanoparticles without antibodies. Studies evidenced that the antibody-decorated nanoparticles did not produce any severe cytotoxic effects on murine glioma cells. Preclinical MRI studies demonstrated that the Fe@C-(CH2)2-CONH-anti-CD61 nanoparticle-based construct specifically targeted murine glioma in animals.
Conclusion
The carbon-encapsulated iron nanoparticles functionalized with monoclonal antibodies recognizing the beta-3 subunit of the integrin αVβ3 receptor can be considered as a potential contrast agent for MRI-based tracking glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
- Department of Physical Chemistry, Faculty of Chemistry, Warsaw University, Warsaw, Poland.
- Department of Organic Chemistry, Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.
ORCID-Profile: Agnieszka Stawarska, Magdalena Bamburowicz-Klimkowska
Zitieren
APA
Stawarska, A., Bamburowicz-Klimkowska, M., Bystrzejewski, M., Kasprzak, A., & Grudzinski, I. P. (2025). Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma. International Journal of Nanomedicine, Volume 20, 5475-5488. https://doi.org/10.2147/ijn.s511286
Vancouver
Stawarska A, Bamburowicz-Klimkowska M, Bystrzejewski M, Kasprzak A, Grudzinski IP. Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma. International Journal of Nanomedicine. 2025;Volume 20:5475-5488. doi:10.2147/ijn.s511286
BibTeX
@article{Stawarska2025,
author = {Stawarska, Agnieszka and Bamburowicz-Klimkowska, Magdalena and Bystrzejewski, Michał and Kasprzak, Artur and Grudzinski, Ireneusz P},
title = {Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {5475--5488},
doi = {10.2147/ijn.s511286}
}
EUVIMED